Please Wait...

ClinPlan

Budget Management and Cash Forecasting for Clinical Trials

Financial management starts with forecasting, and wouldnt it be a benefit to reduces the time to generate a forecast, improve your forecast accuracy, and easily identify delays and expense increases by trial phase?. Bioclinica's forecasting tools help sponsors and CROs efficiently and frequently assess trial expense needs based on activities, such as site and subject enrollment, in order to proactively plan for funds necessary to support the needed ongoing expenses of a clinical trial. This automation fosters collaborative, more accurate financial reporting, reduces the variance between budgeted and actual expense views, to help speed valuable new drug products to market.

With Bioclinica Forecasting, sponsors and CROs benefit from:

Consolidated Budgets

Consolidated Budgets

  • Store and maintain budgets in one location from a variety of vendors and sources that contribute to total trial expense
  • Reduce time operations staff spend on analyzing individual vendor budget spreadsheets to manage the total trial budget

 

Reduction in Variance

Reduction in Variance

  • Reforecast trial expenses regularly by importing real-time data, resulting in proactive decision-making and reduction in variance between budgeted and actual budgets
  • Strengthen sponsor-CRO relationships and retain high-enrolling, high-performing sites for your studies

 

Improved Cash Management

Improved Cash Management

  • Import global expense profiles for participating geographic regions, site activation/enrollment data, and expected schedule of assessment profiles and related expenses
  • Evaluate and reevaluate costs using actual trial data once operational activity begins, to show how the status of the study impacts the funds necessary, preventing under or over-requesting for funds

Download our ClinPlan Data Sheet

ADDITIONAL RESOURCES

Bioclinica Financial Lifecycle Solutions Platform

Download Overview SHEET

6 Reasons Why You Should Choose Bioclinica's Financial Lifecycle Solutions

Download Infographic

Streamline Clinical Trial Financial Lifecycles with Bioclinica's ClinPlan + ClinPay Integration

Download Infographic

Challenges with Cash Management and Reforecasting Clinical Trials

Download eBook

ROI Initiative: A Technology Solution for Investigator Payments

Download eBook

Budget Management & Forecasting for Clinical Trials

Download eBook

Embracing Clinical Trial Technology

Download eBook

Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

Clinical Supplies Teams: Ring in the New Year with the insight needed to get the right drug to the right site and r… https://t.co/3sYmnxVQqu
bioclinica (5 hours ago)
Great advice from our Dir. Cardiovascular Imaging on how to achieve top quality imaging acquisitions & assessments… https://t.co/P57970FrOf
bioclinica (Yesterday)
RT @CenterWatch: #CWWeekly: The increasing trend of adopting digital health and #mhealth apps for patient care. Read more, https://t.co/wo9…
bioclinica (Yesterday)
RT @CenterWatch: Examining the difference between #patient engagement & patient recruitment. Read more in #CWPulse by @AshleyTointon, https…
bioclinica (Yesterday)
RT @CenterWatch: How can #socialmedia play a role in health disparities and #clinicaltrial patient recruitment? Read more in #CWPulse by @A…
bioclinica (Yesterday)
RT @RAPSorg: What New @FDAcdrhIndustry Guidance is Coming in FY 2018: Alternative 510(k) Pathway and More | #Regulatory Recon https://t.co/…
bioclinica (Yesterday)

Latest Blogs:

Removing Risk from Clinical Trial Management System (CTMS) Implementations
Collaboration Between Clinical Operations and the Logistics and Supply Chain Teams is Key to Trial Success
The Value of Protocol Review
CTMS and RBM: Hot Topics at OCT Nordics in Copenhagen
Congressman Meehan and Bioclinica CEO John Hubbard at recent visit to Bioclinica's Audubon offices